EP3846875A4 - Système et méthode pour l'élimination d'inhibiteurs immunitaires de fluides biologiques - Google Patents

Système et méthode pour l'élimination d'inhibiteurs immunitaires de fluides biologiques Download PDF

Info

Publication number
EP3846875A4
EP3846875A4 EP19920634.3A EP19920634A EP3846875A4 EP 3846875 A4 EP3846875 A4 EP 3846875A4 EP 19920634 A EP19920634 A EP 19920634A EP 3846875 A4 EP3846875 A4 EP 3846875A4
Authority
EP
European Patent Office
Prior art keywords
removal
biological fluids
immune inhibitors
immune
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP19920634.3A
Other languages
German (de)
English (en)
Other versions
EP3846875A1 (fr
Inventor
Steven Josephs
Matthew Ong
Amir Jafri
Robert Segal
Stephen Prince
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunicom Inc
Original Assignee
Immunicom Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunicom Inc filed Critical Immunicom Inc
Publication of EP3846875A4 publication Critical patent/EP3846875A4/fr
Publication of EP3846875A1 publication Critical patent/EP3846875A1/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/362—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits changing physical properties of target cells by binding them to added particles to facilitate their subsequent separation from other cells, e.g. immunoaffinity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3687—Chemical treatment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A61M2202/0415—Plasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/75—General characteristics of the apparatus with filters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Anesthesiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • External Artificial Organs (AREA)
EP19920634.3A 2019-11-19 2019-11-19 Système et méthode pour l'élimination d'inhibiteurs immunitaires de fluides biologiques Pending EP3846875A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2019/062177 WO2021101519A1 (fr) 2019-11-19 2019-11-19 Système et méthode pour l'élimination d'inhibiteurs immunitaires de fluides biologiques

Publications (2)

Publication Number Publication Date
EP3846875A4 true EP3846875A4 (fr) 2021-07-14
EP3846875A1 EP3846875A1 (fr) 2021-07-14

Family

ID=75980821

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19920634.3A Pending EP3846875A1 (fr) 2019-11-19 2019-11-19 Système et méthode pour l'élimination d'inhibiteurs immunitaires de fluides biologiques

Country Status (8)

Country Link
EP (1) EP3846875A1 (fr)
JP (2) JP7159493B2 (fr)
KR (2) KR102491518B1 (fr)
CN (1) CN114650852A (fr)
AU (3) AU2019474912B2 (fr)
CA (2) CA3165330A1 (fr)
IL (2) IL301912A (fr)
WO (1) WO2021101519A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11224858B1 (en) 2020-10-01 2022-01-18 Immunicom, Inc. Reduced leaching of a ligand
IL301787A (en) * 2020-10-01 2023-05-01 Immunicom Inc Reduced filtration of ligand

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140303542A1 (en) * 2013-03-14 2014-10-09 Brian J. LeBerthon Method and device for treating cancer
WO2018020285A2 (fr) * 2016-07-28 2018-02-01 Captec Medical Kft. Dispositif de capture d'écoulement et procédé d'élimination de cellules du sang
US20190247560A1 (en) * 2018-02-13 2019-08-15 Gambro Lundia Ab Extracorporeal devices and methods of treating complement factor related diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3901216B2 (ja) * 1995-02-16 2007-04-04 株式会社カネカ 腫瘍壊死因子−αの吸着剤、吸着除去方法および前記吸着剤を用いた吸着器
US8197430B1 (en) * 1998-05-22 2012-06-12 Biopheresis Technologies, Inc. Method and system to remove cytokine inhibitor in patients
JP4150838B2 (ja) * 1999-11-02 2008-09-17 株式会社カネカ 充填物流出防止用フィルタ及びそれを装着した吸着器
CN101124315A (zh) * 2003-01-17 2008-02-13 伊势龙医学股份有限公司 利用凝集素亲和性血液透析去除血液中病毒的方法
JP4925159B2 (ja) * 2005-10-12 2012-04-25 日機装株式会社 血液浄化装置
EP2187957A4 (fr) * 2007-08-31 2011-08-24 Univ Michigan Dispositifs permettant d'effectuer une cytaphérèse sélective et procédés associés
US9717841B2 (en) * 2012-09-11 2017-08-01 Gary L. McNeil Closed-circuit device and methods for isolation, modification, and re-administration of specific constituents from a biological fluid source
DK3110977T3 (en) * 2014-02-28 2018-07-23 Exosome Sciences Inc BRAIN SPECIFIC EXOSOME-BASED DIAGNOSTIC AND EXTRACORPORAL THERAPIES
JP6480447B2 (ja) * 2014-07-22 2019-03-13 旭化成メディカル株式会社 ヒストンを除去する吸着材及び生体由来液浄化デバイス
DE102018104177A1 (de) * 2018-02-23 2019-08-29 B. Braun Avitum Ag Vorrichtung zur Entfernung von Noxen aus Blut, extrakorporales Perfusionssystem mit einer solchen Vorrichtung sowie Verfahren zur Herstellung einer solchen Vorrichtung

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140303542A1 (en) * 2013-03-14 2014-10-09 Brian J. LeBerthon Method and device for treating cancer
WO2018020285A2 (fr) * 2016-07-28 2018-02-01 Captec Medical Kft. Dispositif de capture d'écoulement et procédé d'élimination de cellules du sang
US20190247560A1 (en) * 2018-02-13 2019-08-15 Gambro Lundia Ab Extracorporeal devices and methods of treating complement factor related diseases

Also Published As

Publication number Publication date
AU2022203249A1 (en) 2022-06-23
CA3153685A1 (fr) 2021-05-27
AU2019474912B2 (en) 2022-02-17
CA3153685C (fr) 2022-10-11
IL289438A (en) 2022-02-01
CN114650852A (zh) 2022-06-21
JP7159493B2 (ja) 2022-10-24
WO2021101519A1 (fr) 2021-05-27
JP2023015053A (ja) 2023-01-31
AU2022203249B2 (en) 2023-08-31
JP2022535604A (ja) 2022-08-09
IL289438B1 (en) 2023-05-01
CA3165330A1 (fr) 2021-05-27
KR20220039724A (ko) 2022-03-29
IL289438B2 (en) 2023-09-01
AU2019474912A1 (en) 2022-01-06
EP3846875A1 (fr) 2021-07-14
AU2023274130A1 (en) 2023-12-21
IL301912A (en) 2023-06-01
KR20230016032A (ko) 2023-01-31
KR102491518B1 (ko) 2023-01-20

Similar Documents

Publication Publication Date Title
EP3612930A4 (fr) Système et procédé pour implémenter différents types de contrats à chaîne de blocs
EP3701383A4 (fr) Système et procédé pour exécuter différents types de contrats de chaîne de blocs
EP3826962A4 (fr) Système de filtration de fluide et procédé d'utilisation
EP3698010A4 (fr) Procédé et système de diffusion contrôlée de fluides inconnus
EP3752943A4 (fr) Système et procédé de détection de cyberattaque à partir d'un canal latéral
IL289438B1 (en) System and method for removing immunosuppressants from biological fluids
EP3876495A4 (fr) Procédé et système pour faire fonctionner un dispositif de l'internet des objets
EP4013279A4 (fr) Système et procédé de nettoyage semi-autonome de surfaces
EP3844434A4 (fr) Procédé et système de traitement de biogaz
EP3894097A4 (fr) Système et procédé de modification de substrats
EP4010507A4 (fr) Système et procédé de traitement de boue rouge
EP3948721A4 (fr) Système et procédé d'identification des équivalents de l'achèvement des tâches
EP4010902A4 (fr) Système et procédé d'évaluation du risque de la sclérose en plaques
EP3884221A4 (fr) Procédé et appareil de congélation de produits biologiques
EP3949435A4 (fr) Système et procédé de détection de fluides dans l'oreille moyenne
EP3884204A4 (fr) Système et procédé de fonctionnement autonome de conduite et de systèmes d'installation de secteur intermédiaire
EP3773186A4 (fr) Procédé et système pour évaluation d'un flux sanguin
EP4034952A4 (fr) Procédé et système d'identification et d'analyse de changement de régime
EP3994101A4 (fr) Systèmes et procédés d'élimination de contaminants d'un liquide
GB202115550D0 (en) System and method for management of substances
EP3810805A4 (fr) Procédé de détection et de quantification de modifications génétiques
EP3437672A4 (fr) Système de purification du sang et procédé d'amorçage associé
EP3454961A4 (fr) Procédé et système de purification d'huile
IL287180A (en) A method and system for classifying samples
EP3972877A4 (fr) Système et procédé de dépôt de fluide

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17P Request for examination filed

Effective date: 20200929

A4 Supplementary search report drawn up and despatched

Effective date: 20210401

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

17Q First examination report despatched

Effective date: 20210625

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)